Location: Home
  • search
  • go
  • Relate News
  • 2/20/2023CDE Issues the Technical Guidelines for Microbial Limit Study of Non-s...
  • 2/17/2023JPO Initiates Info Submission of the 8th VBP Officially
  • 2/17/2023Drug R&D and Product Registration News Digest February 2023 (3)
  • 2/17/2023Recent Executive Moves
  • 2/17/2023Official Translation: Provisions for Supervision and Administration of...
  • 2/16/2023China's Rural COVID Wave Exposes Flaws in Tiered Healthcare System (Ca...
  • 2/16/2023CDE Issues the Guidelines for Design and Protocol Frameworks for Real-...
  • 2/16/2023CDE Issues the Guidelines for Communication of Real-World Evidence to ...
  • 2/16/2023IQVIA: Chinese Pharma to See 2%-5% CAGR Before 2027
  • 2/16/2023CDE Issues the Guidelines for Pharmaceutical Research of Generic Solut...
  • 2/15/2023Biogen Cuts $125M MS Partnership with Innocare
  • 2/15/2023CMJ Study Highlights Epilepsy Trends in China between 1990 and 2019
  • 2/15/2023Trends in Respiratory Diseases Before and After COVID-19 in China
  • 2/15/2023NHSA Issues Notice on Incorporation of Designated Retail Pharmacies in...
  • 2/15/2023A Rational Approach to Tapping China's Growing Digital Health Trend (B...
  • 2/14/2023Chinese Drugmakers Start 2023 with a Renewed Influx of Capital (Pharma...
  • 2/14/2023NMPA Issues the Special Rules for TCM Registration
  • 2/14/2023CDE Issues the Technical Guidelines for Research on Quality Attributes...
  • 2/14/2023CDE Seeks Comments on Draft ICH Guidelines M13A
  • 2/14/2023Hengrui and Treeline Enter $706M Licensing Deal for EZH2 inhibitor SHR...
  • 2/14/2023Cullinan and HBM Sign Licensing Deal for B7H4 x 4-1BB Bispecific Immu...
  • 2/14/2023CDE Issues the Guidelines for Clinical Evaluation of Radioactive In Vi...
  • 2/13/2023Nona Biosciences Enters into HCAb Based Antibody Discovery Collaborati...
  • 2/13/2023Lantheus Acquires Cerveau and Its Tau-spotting PET Tracer for Alzheime...
  • 2/13/2023CDE Issues the Guidelines for Clinical Development of New Drugs for Ac...
  • 2/13/2023CDE Issues the Guidelines for Clinical Trials of Drug Therapies for Pr...
  • 2/13/2023CDE Issues the Guidelines for Pharmaceutical Study and Assessment of O...
  • 2/13/2023Corbus Licenses Clinical Stage Nectin-4 Targeting ADC from CSPC Megal...
  • 2/13/2023Clover Launches COVID-19 Booster Vaccine in China
  • 2/10/2023China Drug Sales Performance of Top Seven MNC Pharma Cos in 2022
  • Page:112/775 Total number of articles:23243: [First][<<] [110] [111] [112] [113] [114] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group